Commercial
Commercial, Wednesday 24 April 2024
Commercial
11:24Chair's Remarks
Kristin Marvin-Keller, Managing Director, Havas Life Rare
Commercial
11:25NIH as your technology development and commercialization partner
Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU), National Institute of Health (NIH)
Commercial
11:45Commercialization in rare disease
Lindy Forte, Senior Vice President, Market Access and Pricing, EVERSANA
Commercial
12:05Building commercial teams for a successful pre-launch
Moderator: Kevin Baruzzi, Partner, Simon-Kucher & Partners Strategy & Marketing Consultants GmbH
Joshua Prabhakar, Vice President, Novartis Gene Therapies
Ron Cooper, Former CEO, Albireo Pharma
Wills Hughes-Wilson, Chief Patient Access & Commercial Planning, Mereo Biopharma
Jason Tardio, Chief Operating Officer, Ovid Therapeutics
Commercial
12:45Patient engagement strategy earlier in commercial planning
Melissa Williams, Founder, Simply Patient
Commercial
13:05Meet the moment for advanced therapies: Past learnings, present state and collaborating for the future
Tim Hunt, Chief Executive Officer, Alliance for Regenerative Medicine
Shaun Ellis, Vice President, Global Market Access Specialty Ophthalmology, Johnson & Johnson
Commercial
14:59Chair's Remarks
Kristin Marvin-Keller, Managing Director, Havas Life Rare
Commercial
15:00Use of machine learning to improve time to diagnosis of patients with probable MPS II: A case study
Pierantonio Russo, FCCP, FAAP, STS, Corporate Chief Medical Officer, EVERSANA
Ramaa Nathan, VP of Data Science and Real-World Evidence, EVERSANA
Commercial
15:20Commercializing in the ultra-orphan space: Unique challenges and opportunities
Moderator: Kristin Marvin-Keller, Managing Director, Havas Life Rare
Commercial
16:00What it takes to order that one test by physicians
Pierantonio Russo, FCCP, FAAP, STS, Corporate Chief Medical Officer, EVERSANA
last published: 16/Apr/24 04:05
Commercial, Thursday 25 April 2024
Commercial
12:00Commercial strategy for rare diseases
Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy
Commercial
12:20AI, insights and technology transformations within rare diseases
Inderpreet Kambo, Principal (Partner) - Information Management & Analytics, IQVIA
Commercial
12:40Transformative launch strategies: Commercializing orphan products for success
Moderator: Simone Seiter, Senior Partner, Simon-Kucher & Partners Strategy & Marketing Consultants GmbH
Neha Kumar, Global Commercial Strategy - Precision Medicine, Johnson & Johnson Innovative Medicine
Tsveta Milanova, Chief Commercial Officer, Agios Pharmaceuticals
Grant Castor, SVP Commercial Strategy & Operations, Sentynl Therapeutics
last published: 16/Apr/24 04:05
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events